About Septalyst
Septalyst is a Healthcare company based in Thane (India) founded in 2010. Development and distribution of pharmaceutical products for healthcare sectors in India. The company has 131 employees. Its Indian entity Septalyst Lifesciences Private Limited reported revenue of ₹51.21 Cr. Septalyst offers products and services including Renal Medicines and Anti-Depressants. Its focus areas include Pharmaceuticals, Medicines, Nephrology and Neurology.
Company details
Septalyst is known for its focus on pharmaceuticals aimed at preventing health issues in India, where factors like stress and pollution are recognized as contributors to kidney and nervous system problems. Efforts are made by the company to provide affordable medicines and raise awareness through knowledge dissemination, ensuring patient compliance and public health protection. As a 15-year-old organization, collaborations with the industry are encouraged to enhance overall health outcomes, demonstrating that business and medical purposes can be aligned effectively.
- Headquarters Thane, India
- Employees 131
- SectorsHealthcare
- Email••••••••
- Website septalyst.com
- Social LinkedIn Facebook
- Legal Name Septalyst Lifesciences Private Limited
- Date of Incorporation 10 Jun, 2010
- Jurisdiction Thane, Maharashtra, India
- Annual Revenue₹51.21 Cr
FY 2024 · +28% YoY
- Net Profit₹60.4 Lakh
FY 2024 · 1% margin
- EBITDA₹2.55 Cr
FY 2024 · 5% margin
- Employee Count131
Associated legal entities of Septalyst
Septalyst operates through Septalyst Lifesciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Septalyst Lifesciences Private Limited CIN U74900MH2010PTC203994 | Active | 10 Jun 2010 | Thane, Maharashtra | ₹51.2 Cr | 131 | 5 | View details |
Products & Services of Septalyst
Septalyst offers a comprehensive portfolio of products and services, including Renal Medicines and Anti-Depressants.
Renal medicines for kidney disorders are developed and distributed by Septalyst.
Anti-depressants for neurological conditions are provided by Septalyst.
Board of directors of Septalyst Lifesciences Private Limited (Septalyst)
Septalyst Lifesciences Private Limited is the primary company behind Septalyst. The board of Septalyst Lifesciences Private Limited currently have 5 directors; the longest-serving is Shyam Sunder Singh, appointed in 2010.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shyam Sunder Singh DIN 03010839 | Managing Director | 10 Jun 2010 | 16 yrs 4 mo | Septalyst Lifesciences Private Limited |
| Vishal Gourav Bohidar DIN 03018210 | Director | 10 Jun 2010 | 16 yrs 4 mo | Septalyst Lifesciences Private Limited |
| Yogesh Prabhudyal Sharma DIN 00184511 | Director | 10 Jun 2010 | 16 yrs 4 mo | Septalyst Lifesciences Private Limited |
| Bhaskar Shivprasad Mamgai DIN 09375306 | Director | 26 Oct 2021 | 5 yrs | Septalyst Lifesciences Private Limited |
| Ajeet Singh DIN 09370195 | Director | 26 Oct 2021 | 5 yrs | Septalyst Lifesciences Private Limited |
Financials of Septalyst
Figures of Septalyst Lifesciences Private Limited, the primary company behind Septalyst, for FY 2024. Revenue was ₹51.21 Cr (+28% year on year). Net profit was ₹60.4 Lakh (1% margin). EBITDA was ₹2.55 Cr (5% margin). Revenue has grown at a compounded annual rate of +11% over three years and +7% over five years.
- ₹51.21 CrRevenue · FY 2024 · +28% YoY
- ₹60.4 LakhNet profit · 1% margin
- ₹2.55 CrEBITDA · 5% margin
- ₹2.3 LakhPaid-up capital
- 131Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Septalyst Lifesciences Private Limited are on its company page.
Detailed financial statements for Septalyst
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Septalyst
The website of Septalyst (septalyst.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▲ 13.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Septalyst
Complete news archive for Septalyst
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Septalyst
Septalyst was founded in 2010.
Septalyst is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.
Septalyst has 131 employees.
The primary company behind Septalyst, Septalyst Lifesciences Private Limited, reported revenue of ₹51.21 Cr for FY 2024, up 28% year on year.
Septalyst is known for its focus on pharmaceuticals aimed at preventing health issues in India, where factors like stress and pollution are recognized as contributors to kidney and nervous system problems. Efforts are made by the company to provide affordable medicines and raise awareness through knowledge dissemination, ensuring patient compliance and public health protection. As a 15-year-old organization, collaborations with the industry are encouraged to enhance overall health outcomes, demonstrating that business and medical purposes can be aligned effectively.
Septalyst offers Renal Medicines and Anti-Depressants.
Septalyst operates through Septalyst Lifesciences Private Limited.
The legal entities of Septalyst currently have 5 directors, including Shyam Sunder Singh, Bhaskar Shivprasad Mamgai, Ajeet Singh and others.